3min chapter

Investing With IBD cover image

Ep. 195: Jim Roppel: Stock Market Lessons Of 2022

Investing With IBD

CHAPTER

Sena Corps Blows Up on FDA Victory

There's a gaggle of not golden geese, but there's about 15 Biotechs that have a market cap between 500 million and 2 billion. This has earnings. All those others are minefields. They are disasters. I spent six or nine months building this whole position at all, but it all went up in flames. Anything without earnings in biotech is subject to a bad clinical trial on,. You know, that's the non performance. And they're super illiquid time. They're little lotto tickets.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode